Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Oral Linezolid 300 mg/Day in Healthy Volunteers
NCT03841721Phase 1Unknown
- Sponsor
- Prince of Songkla University
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of linezolid in Tuberculosis (TB), sponsored by Prince of Songkla University. Primary endpoint: Concentration of linezolid in plasma at 24 hours. Status: unknown.
02
Drugs
linezolid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03841721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841721.